Tensred Plus14 Mar 2023 17:51
First noted tensred back on Opti bb on 14 Dec 2021 - anyway bit more up to date info below and the relative recent release of tensred plus
https://www.nutritioninsight.com/technical-papers/tensred-plus%C2%AE-by-biofarma-group-a-clinically-validated-nutraceutical-support-to-manage-pre-hypertension.html
from above to below
https://www.biofarmagroup.it/en/innovative-nutraceutical-solution-pre-hypertension-biofarma-group/
extract
The observation was performed on a sample of 40 patients over 18 and of both sexes with pre-hypertension. They were asked to take the nutraceutical composition for several months, once a day at breakfast time. The main results obtained from the clinical study are as follows: a significant reduction in mean systolic blood pressure (SBP -4.1 mmHg, p= 0.041) and mean diastolic blood pressure (DBP -3.0 mmHg, p= 0.044) was observed, the focus of the investigation. Although these values can suggest a result that is not particularly significant if we consider that the object of the observation is a nutraceutical product used on substantially still healthy subjects who are only in a situation at risk of developing the disease. In addition, a significant reduction in total cholesterol (CT -13.5 mg/dl) and low-density lipoproteins, more commonly known as “bad cholesterol” (LDL-C -11.4 mg/dl), was also observed.
In conclusion, you can say that the clinical trial demonstrated the efficacy of the identified nutraceutical compound to support patients with pre-hypertension, reducing blood pressure values and counteracting the progression of the state toward one of the hypertension arteries a. This is a significant result, especially if we consider that this is one of the few, if not, the only pilot study which evaluated subjects in a state of pre-hypertension, consistent with the increasing importance attributed by the medical community to timely intervention in this preliminary phase of the disease.
From these results, Tensred plus® was born, whose effectiveness is therefore given by the synergy of four mechanisms of action: L-arginine, an amino acid considered vasodilator; Vitamin B1 (thiamine) that contributes to the normal functioning of the heart (EFSA authorized claim); L. Plantarum LPLDL®, which improves blood pressure through mechanisms that include improving total cholesterol and low-density lipoprotein cholesterol levels, reducing blood glucose level and insulin resistance; in fine Coenzyme Q10, antioxidant able to act on both systolic and diastolic pressure and whose deficiency is therefore associated with cardiovascular diseases.
mol
Sign In
Follow the stocks
